GLP-1 as a tablet: how oral treatment works
Turning a peptide medicine into a tablet is a small technical feat, and it changes your daily routine. Why the intake rules are so strict and who the tablet form may suit.
- GLP-1
- tablet
- semaglutide
In short
GLP-1 treatment doesn't only come as an injection. The active substance semaglutide is also available as a tablet taken once a day.
Same substance, different routine: the tablet only works if you take it on an empty stomach and leave a gap before breakfast. Whether the tablet form is an option for you, and at what dose, is a medical decision.
Why a tablet is so much harder than an injection
Semaglutide is a peptide, a small protein molecule. And protein is exactly what your stomach is built to break down: stomach acid and digestive enzymes take it apart long before it can reach the blood. That's why GLP-1 medicines were injection-only for a long time.
The tablet gets round this with an excipient called SNAC. It briefly shields the active substance from stomach acid and helps it pass through the stomach lining. Even so, only a very small share reaches the blood. That's why a tablet contains much more active substance than an injection; the higher milligram figure doesn't mean it is stronger.
How intake works
Because absorption is so delicate, the rules are stricter than for the injection. The exact instructions are in the package leaflet. In principle:
- Take it in the morning on an empty stomach
- Swallow it with only a small sip of water, no other drinks
- Then wait a set time before eating, drinking or taking other medicines
- Swallow the tablet whole; don't split, chew or crush it
- If these rules aren't followed, less active substance is absorbed and the effect can weaken.
What this means for your day
Coffee as soon as you're up, a thyroid tablet with breakfast, rushing out to work: routines like these have to be rearranged around the intake window. If you need to take other medicines on an empty stomach in the morning, clarify the order with a doctor or pharmacist beforehand.
In return there's no injecting and no need to refrigerate the tablets, which can be a real advantage on the go or when travelling.
What the studies show
The tablet at its approved dose was studied in the OASIS 4 trial, where it led to clearly greater weight loss than placebo, in each case alongside diet and exercise. The earlier OASIS 1 trial tested a higher dose that is not approved.
Studies give averages under controlled conditions. How things go for you depends, among other things, on how well intake fits your daily life and how you tolerate the medicine. Whether and how a switch or a dose change happens is decided by the doctor in each individual case.
Side effects
Because the active substance is the same, side effects are similar to those of the injection. They mainly affect the gut and tend to show up when the dose is increased:
- Nausea, feeling full, burping
- Diarrhoea or constipation
- Vomiting
- Headache and tiredness, often linked to drinking too little
- Vomiting and diarrhoea can reduce the effectiveness of the contraceptive pill
- Seek medical help immediately for severe, persistent abdominal pain that may spread to the back
Who the tablet form may suit
The tablet is prescription-only and is only prescribed for its approved indications, not as a general diet aid. For weight management that usually means adults with a BMI of 30 or more, or 27 or more with a weight-related condition.
Since July 2026 the tablet form has been approved in the EU for weight management, and it is available in Germany. Whether it is an option for you is assessed in the medical review of your questionnaire.
Tablet or injection?
| Attribute | Tablet | Injection |
|---|---|---|
| Rhythm | daily | once a week |
| Intake rules | empty stomach, little water, wait before eating | independent of meals and time of day |
| Storage | no refrigeration needed | unopened in the fridge |
| Good fit if | you'd rather avoid needles and have a steady morning routine | you'd rather not think about a time window every day |
Frequently asked questions
Note
This Journal article offers general information. It is not a diagnosis, a prescription or a promise of any result. Whether treatment is suitable for you is decided by a doctor after reviewing your questionnaire. For acute or severe symptoms, contact your GP, the out-of-hours medical service (116117) or, in an emergency, 112. Whether and how a switch or a dose change happens is decided by the doctor in each individual case.
Sources and medical review
Based on European Medicines Agency product information for oral semaglutide and the OASIS 4 and OASIS 1 trials. Educational only; does not replace an individual medical decision.
- European Medicines Agency product information for oral semaglutide
- Knop FK et al. Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1). Lancet 2023
- Wharton S et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS 4). N Engl J Med 2025